• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is gemcitabine plus vinorelbine active in second-line chemotherapy of metastatic breast cancer? a single-center phase 2 study.

作者信息

Rossi Emanuela, Perrone Francesco, Labonia Vincenzo, Landi Gabriella, Nuzzo Francesco, Amabile Gerardo, Gridelli Cesare, Di Maio Massimo, D'Aiuto Giuseppe, de Matteis Andrea

出版信息

Oncology. 2003;64(4):479-80. doi: 10.1159/000070313.

DOI:10.1159/000070313
PMID:12759551
Abstract
摘要

相似文献

1
Is gemcitabine plus vinorelbine active in second-line chemotherapy of metastatic breast cancer? a single-center phase 2 study.吉西他滨联合长春瑞滨在转移性乳腺癌二线化疗中是否有效？一项单中心2期研究。
Oncology. 2003;64(4):479-80. doi: 10.1159/000070313.
2
Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: results of a multicenter phase II study.多西他赛联合表柔比星或长春瑞滨一线治疗转移性乳腺癌后序贯每周多西他赛和吉西他滨：一项多中心II期研究结果
Tumori. 2006 Jan-Feb;92(1):6-12. doi: 10.1177/030089160609200102.
3
Gemcitabine combination chemotherapy in metastatic breast cancer: phase II experience.吉西他滨联合化疗用于转移性乳腺癌：II期经验。
Oncology (Williston Park). 2003 Dec;17(12 Suppl 14):15-21.
4
Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial.吉西他滨联合长春瑞滨对比长春瑞滨单药治疗既往接受过蒽环类和紫杉类治疗的转移性乳腺癌患者：西班牙乳腺癌研究组（GEICAM）III期试验的最终结果
Lancet Oncol. 2007 Mar;8(3):219-25. doi: 10.1016/S1470-2045(07)70041-4.
5
Second-line neoadjuvant vinorelbine and gemcitabine combination in locally advanced breast cancer showing no early response to TAC.多西他赛、多柔比星和环磷酰胺方案新辅助化疗后局部晚期乳腺癌无早期缓解者接受长春瑞滨和吉西他滨二线治疗
Med Oncol. 2012 Jun;29(2):454-8. doi: 10.1007/s12032-011-9868-1. Epub 2011 Feb 25.
6
Gemcitabine in combination with vinorelbine for treatment of advanced breast cancer.
Clin Breast Cancer. 2002 May;3 Suppl 1:34-8. doi: 10.3816/cbc.2002.s.008.
7
Vinorelbine Plus Gemcitabine or Cisplatin as First-line Treatment of HER2-negative Advanced Breast Cancer.长春瑞滨联合吉西他滨或顺铂作为HER2阴性晚期乳腺癌的一线治疗方案
Anticancer Res. 2017 Oct;37(10):5647-5653. doi: 10.21873/anticanres.12000.
8
The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines: a phase I-II study.吉西他滨与长春瑞滨联合用药作为紫杉烷类和/或蒽环类药物预处理后的转移性乳腺癌患者二线治疗的有效方案：一项I-II期研究。
Breast Cancer Res Treat. 2003 Mar;78(1):29-36. doi: 10.1023/a:1022197109592.
9
Gemcitabine/vinorelbine in metastatic breast cancer patients previously treated with anthracyclines: results of a phase II trial.吉西他滨/长春瑞滨用于先前接受过蒽环类药物治疗的转移性乳腺癌患者：一项II期试验的结果
Clin Breast Cancer. 2003 Apr;4(1):46-50. doi: 10.3816/cbc.2003.n.011.
10
[Efficacy and toxicity of gemcitabine combined vinorelbine on metastatic breast cancer: a report of 34 cases].吉西他滨联合长春瑞滨治疗转移性乳腺癌的疗效与毒性：附34例报告
Ai Zheng. 2007 Dec;26(12):1373-6.

引用本文的文献

1
Gemcitabine and vinorelbine combination chemotherapy in anthracycline- and taxane-pretreated advanced breast cancer.吉西他滨和长春瑞滨联合化疗在蒽环类和紫杉类预处理的晚期乳腺癌中的应用。
Cancer Res Treat. 2008 Jun;40(2):81-6. doi: 10.4143/crt.2008.40.2.81. Epub 2008 Jun 30.
2
Biweekly gemcitabine plus vinorelbine in first-line metastatic breast cancer: efficacy and correlation with HER2 extracellular domain.吉西他滨与长春瑞滨双周方案用于一线转移性乳腺癌治疗：疗效及与HER2细胞外结构域的相关性
Clin Transl Oncol. 2006 Dec;8(12):896-902. doi: 10.1007/s12094-006-0153-2.
3
Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study.
吉西他滨持续输注联合长春瑞滨用于蒽环类和/或紫杉烷类预处理的转移性乳腺癌：一项II期研究。
J Cancer Res Clin Oncol. 2005 Sep;131(9):568-74. doi: 10.1007/s00432-005-0675-y. Epub 2005 Oct 20.